127 related articles for article (PubMed ID: 31317190)
1. Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types.
Venturi G; Gomes Ferreira I; Pucci M; Ferracin M; Malagolini N; Chiricolo M; Dall'Olio F
Glycobiology; 2019 Sep; 29(10):684-695. PubMed ID: 31317190
[TBL] [Abstract][Full Text] [Related]
2. The HOTAIR/miR-214/ST6GAL1 crosstalk modulates colorectal cancer procession through mediating sialylated c-Met via JAK2/STAT3 cascade.
Liu B; Liu Q; Pan S; Huang Y; Qi Y; Li S; Xiao Y; Jia L
J Exp Clin Cancer Res; 2019 Nov; 38(1):455. PubMed ID: 31694696
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of ST6GAL1 in the tumor progression of colorectal cancer.
Zhang S; Lu J; Xu Z; Zou X; Sun X; Xu Y; Shan A; Lu J; Yan X; Cui Y; Yan W; Du Y; Gu J; Zheng M; Feng B; Zhang Y
Biochem Biophys Res Commun; 2017 May; 486(4):1090-1096. PubMed ID: 28377225
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of the sialyltransferase ST6GAL1 in ovarian cancer.
Wichert B; Milde-Langosch K; Galatenko V; Schmalfeldt B; Oliveira-Ferrer L
Glycobiology; 2018 Nov; 28(11):898-903. PubMed ID: 30016515
[TBL] [Abstract][Full Text] [Related]
5. N‑glycosylation and receptor tyrosine kinase signaling affect claudin‑3 levels in colorectal cancer cells.
Pérez AG; Andrade-Da-Costa J; De Souza WF; De Souza Ferreira M; Boroni M; De Oliveira IM; Freire-Neto CA; Fernandes PV; De Lanna CA; Souza-Santos PT; Morgado-Díaz JA; De-Freitas-Junior JCM
Oncol Rep; 2020 Oct; 44(4):1649-1661. PubMed ID: 32945502
[TBL] [Abstract][Full Text] [Related]
6. Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells.
Rodrigues JG; Duarte HO; Gomes C; Balmaña M; Martins ÁM; Hensbergen PJ; de Ru AH; Lima J; Albergaria A; van Veelen PA; Wuhrer M; Gomes J; Reis CA
Cell Oncol (Dordr); 2021 Aug; 44(4):835-850. PubMed ID: 33847896
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic changes induced by expression of beta-galactoside alpha2,6 sialyltransferase I in the human colon cancer cell line SW948.
Chiricolo M; Malagolini N; Bonfiglioli S; Dall'Olio F
Glycobiology; 2006 Feb; 16(2):146-54. PubMed ID: 16192407
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of ST6GAL1 in human bladder cancer.
Antony P; Rose M; Heidenreich A; Knüchel R; Gaisa NT; Dahl E
BMC Cancer; 2014 Dec; 14():901. PubMed ID: 25465919
[TBL] [Abstract][Full Text] [Related]
9. Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells.
Dorsett KA; Jones RB; Ankenbauer KE; Hjelmeland AB; Bellis SL
J Ovarian Res; 2019 Oct; 12(1):93. PubMed ID: 31610800
[TBL] [Abstract][Full Text] [Related]
10. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
Scott E; Archer Goode E; Garnham R; Hodgson K; Orozco-Moreno M; Turner H; Livermore K; Putri Nangkana K; Frame FM; Bermudez A; Jose Garcia Marques F; McClurg UL; Wilson L; Thomas H; Buskin A; Hepburn A; Duxfield A; Bastian K; Pye H; Arredondo HM; Hysenaj G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Heer R; Maitland NJ; Whitaker H; Pitteri S; Troyer DA; Wang N; Elliott DJ; Drake RR; Munkley J
J Pathol; 2023 Sep; 261(1):71-84. PubMed ID: 37550801
[TBL] [Abstract][Full Text] [Related]
11. Regulation of ST6GAL1 sialyltransferase expression in cancer cells.
Dorsett KA; Marciel MP; Hwang J; Ankenbauer KE; Bhalerao N; Bellis SL
Glycobiology; 2021 Jun; 31(5):530-539. PubMed ID: 33320246
[TBL] [Abstract][Full Text] [Related]
12. ST6Gal1 in plasma is dispensable for IgG sialylation.
Oswald DM; Lehoux SD; Zhou JY; Glendenning LM; Cummings RD; Cobb BA
Glycobiology; 2022 Aug; 32(9):803-813. PubMed ID: 35746897
[TBL] [Abstract][Full Text] [Related]
13. Loss of core fucosylation in both ST6GAL1 and its substrate enhances glycoprotein sialylation in mice.
Huang G; Li Z; Li Y; Liu G; Sun S; Gu J; Kameyama A; Li W; Dong W
Biochem J; 2020 Mar; 477(6):1179-1201. PubMed ID: 32141499
[TBL] [Abstract][Full Text] [Related]
14. Comparison of α2,6-sialyltransferases for sialylation of therapeutic proteins.
Janesch B; Saxena H; Sim L; Wakarchuk WW
Glycobiology; 2019 Sep; 29(10):735-747. PubMed ID: 31281932
[TBL] [Abstract][Full Text] [Related]
15. ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface.
Zou X; Lu J; Deng Y; Liu Q; Yan X; Cui Y; Xiao X; Fang M; Yang F; Sawaki H; Sato T; Tan B; Lu X; Feng B; Kuno A; Narimatsu H; Gao C; Zhang Y
Oncogene; 2023 Feb; 42(7):516-529. PubMed ID: 36528750
[TBL] [Abstract][Full Text] [Related]
16. Sialylation of MUC4β N-glycans by ST6GAL1 orchestrates human airway epithelial cell differentiation associated with type-2 inflammation.
Zhou X; Kinlough CL; Hughey RP; Jin M; Inoue H; Etling E; Modena BD; Kaminski N; Bleecker ER; Meyers DA; Jarjour NN; Trudeau JB; Holguin F; Ray A; Wenzel SE
JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30730306
[TBL] [Abstract][Full Text] [Related]
17. The role of DNA methylation in ST6Gal1 expression in gliomas.
Kroes RA; Moskal JR
Glycobiology; 2016 Dec; 26(12):1271-1283. PubMed ID: 27510958
[TBL] [Abstract][Full Text] [Related]
18. ST6Gal1 targets the ectodomain of ErbB2 in a site-specific manner and regulates gastric cancer cell sensitivity to trastuzumab.
Duarte HO; Rodrigues JG; Gomes C; Hensbergen PJ; Ederveen ALH; de Ru AH; Mereiter S; Polónia A; Fernandes E; Ferreira JA; van Veelen PA; Santos LL; Wuhrer M; Gomes J; Reis CA
Oncogene; 2021 May; 40(21):3719-3733. PubMed ID: 33947960
[TBL] [Abstract][Full Text] [Related]
19. Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone.
Hodgson K; Orozco-Moreno M; Goode EA; Fisher M; Garnham R; Beatson R; Turner H; Livermore K; Zhou Y; Wilson L; Visser EA; Pijnenborg JF; Eerden N; Moons SJ; Rossing E; Hysenaj G; Krishna R; Peng Z; Nangkana KP; Schmidt EN; Duxfield A; Dennis EP; Heer R; Lawson MA; Macauley M; Elliott DJ; Büll C; Scott E; Boltje TJ; Drake RR; Wang N; Munkley J
EBioMedicine; 2024 Jun; 104():105163. PubMed ID: 38772281
[TBL] [Abstract][Full Text] [Related]
20. Platelet-localized ST6Gal1 does not impact IgG sialylation.
Glendenning LM; Zhou JY; Kukan EN; Gao C; Cummings RD; Joshi S; Whiteheart SW; Cobb BA
Glycobiology; 2023 Dec; 33(11):943-953. PubMed ID: 37379323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
